Logos Global Management LP

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1792126 San Francisco, CA

Position in XENE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$26,167,500

+$4,360,000 QoQ

Shares Held

450,000

-30.8% QoQ

Ownership

0.466%

of shares outstanding

% of Portfolio

1.35%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Logos Global Management LP holds $1,835,814,678 across 59 Biotechnology names. XENE ranks #23 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,000,000	$194,500,000
2	ERAS	Erasca, Inc.	11,150,000	$180,407,000
3	IDYA	IDEAYA Biosciences, Inc.	3,450,000	$114,954,000
4	PRAX	Praxis Precision Medicines, Inc.	285,000	$91,824,150
5	CNTA	Centessa Pharmaceuticals plc	2,125,000	$84,405,000
6	TERN	Terns Pharmaceuticals, Inc.	1,500,000	$79,080,000
7	ABVX	Abivax S.A.	675,000	$75,161,250
8	TNGX	Tango Therapeutics, Inc.	3,000,000	$62,760,000

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$26,167,500	450,000	-30.8%	Shares	Sole	2026-05-15
2025-03-31	$21,807,500	650,000	+73.3%	Shares	Sole	2025-05-15
2024-06-30	$14,621,250	375,000	+150.0%	Shares	Sole	2024-08-27
2023-12-31	$6,909,000	150,000	-66.7%	Shares	Sole	2024-02-14
2023-09-30	$15,372,000	450,000	+63.6%	Shares	Sole	2023-11-14
2023-06-30	$10,587,500	275,000	-69.4%	Shares	Sole	2023-08-14
2023-03-31	$32,211,000	900,000	0.0%	Shares	Sole	2023-05-15
2022-12-31	$35,487,000	900,000	+80.0%	Shares	Sole	2023-02-14
2022-09-30	$18,050,000	500,000	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.